SOHO Highlights: State of the Art and Next Questions
More than 2,500 hematologic oncology specialists from 110 countries participated in the virtual Eighth Annual Meeting of the Society (SOHO 2020) in September. Approximately 170 topics were presented during the 3.5 day meeting from over 100 of the top investigators in the field. Based on popular demand, the Society of Hematologic Oncology (SOHO) will host a one-day program entitled, “SOHO Highlights: State of the Art and Next Questions” on October 28, 2020. The program will highlight the most important data presented at SOHO 2020 [State of the Art] as well as discuss what to expect in the near-term [Next Questions].
The “SOHO Highlights” meeting is designed to provide participants with an overview of the latest advances in hematologic malignancies and a preview of where the field is going next. Investigators from around the world will join the meeting for a day of learning and interactive, virtual discussion with the speakers. Each presentation is 25 minutes followed by a 10-minute, live Questions & Answer session with the audience. Note that the Zoom platform will be utilized to facilitate interaction with attendees.
SOHO Highlights Scientific Program
Wednesday, October 28, 2020 | Virtual Event Venue
Time (UTC -5)* |
Topic |
Speaker |
Affiliation |
8:00 AM |
Welcome & Introduction |
Sagar Lonial, MD, FACP |
President & Chair, SOHO |
8:10 AM |
State of the Art & Next Questions: Acute Lymphoblastic Leukemia |
Hagop Kantarjian, MD |
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA |
8:35 AM |
Audience Q & A |
|
|
8:45 AM |
State of the Art & Next Questions: Acute Myeloid Leukemia |
Amer Zeidan, MBBS |
Yale Cancer Center, New Haven, Connecticut, USA |
9:10 AM |
Audience Q & A |
|
|
9:20 AM |
State of the Art & Next Questions: Cellular Therapy |
Sergio Giralt, MD |
Memorial Sloan Kettering Cancer Center, New York, New York, USA |
9:45 AM |
Audience Q & A |
|
|
9:55 AM |
State of the Art & Next Questions: Chronic Lymphocytic Leukemia |
Jennifer R. Brown, MD, PhD |
Dana-Farber Cancer Institute, Boston, Massachusetts, USA |
10:20 AM |
Audience Q & A |
|
|
10:30 AM |
Break |
|
|
10:45 AM |
State of the Art & Next Questions: Chronic Myeloid Leukemia |
Michael Deininger, MD, PhD |
Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah, USA |
11:10 AM |
Audience Q & A |
|
|
11:20 AM |
State of the Art & Next Questions: Aggressive B-Cell Lymphoma |
Sandeep S. Dave, MD, MS |
Duke University School of Medicine, Durham, North Carolina, USA |
11:45 AM |
Audience Q & A |
|
|
11:55 AM |
State of the Art & Next Questions: Indolent B-Cell Lymphoma |
Robert Marcus, MA, FRCP, FRCPath |
Leaders in Oncology Care, London, United Kingdom |
12:20 PM |
Audience Q & A |
|
|
12:30 PM |
State of the Art & Next Questions: T-Cell Lymphoma |
Kerry Savage, MD |
BC Cancer Agency, Vancouver, British Columbia, Canada |
12:55 AM |
Audience Q & A |
|
|
1:05 PM |
Break |
|
|
1:35 PM |
State of the Art & Next Questions: Mantle Cell Lymphoma |
Jonathon B. Cohen, MD, MS |
Emory University School of Medicine, Atlanta, Georgia, USA |
2:00 PM |
Audience Q & A |
|
|
2:10 PM |
State of the Art & Next Questions:Hodgkin Lymphoma |
David J. Straus, MD |
Memorial Sloan Kettering Cancer Center, New York, New York, USA |
2:35 PM |
Audience Q & A |
|
|
2:45 PM |
State of the Art & Next Questions: Multiple Myeloma |
Sagar Lonial, MD, FACP |
Emory University School of Medicine, Atlanta, Georgia, USA |
3:10 PM |
Audience Q & A |
|
|
3:20 PM |
State of the Art & Next Questions: Myelodysplastic Syndromes |
Guillermo Garcia-Manero, MD |
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA |
3:45 PM |
Audience Q & A |
|
|
3:55 PM |
State of the Art & Next Questions: Myeloproliferative Neoplasms |
Srdan Verstovsek, MD, PhD |
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA |
4:20 PM |
Audience Q & A |
|
|
4:30 PM |
Closing Remarks |
Sagar Lonial, MD, FACP |
President & Chair, SOHO |
4:35 PM |
Adjourn |
|
|
*All times are listed in Central Daylight Time (CDT) which is 5 hours behind Coordinated Universal Time (UTC -5).